Prospective Cohort Study and Emulated Target Trial to Estimate the Safety and Effectiveness of MVA-BN vaccination against MPXV infection in at-risk individuals in Germany (SEMVAc/TEMVAc)

15/12/2022
20/09/2024
EU PAS number:
EUPAS50093
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

20221202_SEMVAc_V1.3 final_shared version

English (534.65 KB - PDF) View document
Study results
Study report
Study report

SEMVAc and TEMVAc_Extended Study Report.pdf

English (4.69 MB - PDF) View document
Other information
Study, other information

Annex 2_Supplementary Material_SEMVAc and TEMVAc extended study report.pdf

English (1.69 MB - PDF) View document